Retraction: Serum fetuin - A levels in patients with cardiovascular disease: A meta-analysis (BioMed Research International (2014) 2014 (691540) DOI: 10.1155/2014/691540);Serum fetuin-A levels in patients with cardiovascular disease: A meta-analysis

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Sun, Ze Lin ^a   Xie, Qi Ying ^a   Guo, Gong Liang ^b   Ma, Ke ^c   Huang, Yuan Yuan ^c  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CHINA JAPAN UNION HOSPITAL OF JILIN UNIVERSITY   (China)

^c THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FETUIN A; AHSG PROTEIN, HUMAN;

ARTICLE; ASIAN; CARDIOVASCULAR DISEASE; CAUCASIAN; DATA BASE; HUMAN; PROTEIN BLOOD LEVEL; PUBLISHING; SENSITIVITY ANALYSIS; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; CARDIOVASCULAR DISEASES; CHINA; DIAGNOSTIC USE; GENETIC PREDISPOSITION; META ANALYSIS; METABOLISM; PATHOLOGY;

ALPHA-2-HS-GLYCOPROTEIN; ASIAN CONTINENTAL ANCESTRY GROUP; CARDIOVASCULAR DISEASES; CHINA; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; HUMANS;

EID: 84908322792     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2020/2013691     Document Type: Erratum

References (36)

1. Aslan M., Dogan S., Proteomic detection of nitroproteins as potential biomarkers for cardiovascular disease. Journal of Proteomics 2011 74 11 2274 2288 10.1016/j.jprot.2011.05.029 2-s2.0-80054868098
2. Yusuf S., Islam S., Chow C. K., Rangarajan S., Dagenais G., Diaz R., Gupta R., Kelishadi R., Iqbal R., Avezum A., Kruger A., Kutty R., Lanas F., Liu L., Wei L., Lopez-Jaramillo P., Oguz A., Rahman O., Swidan H., Yusoff K., Zatonski W., Rosengren A., Teo K. K., Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey. The Lancet 2011 378 9798 1231 1243 10.1016/S0140-6736(11)61215-4 2-s2.0-80053563341
3. Go A. S., Mozaffarian D., Roger V. L., Heart disease and stroke statistics-2014 update: a report from the American Heart Association. Circulation 2014 129 e28 e292
4. Finks S. W., Airee A., Chow S. L., Macaulay T. E., Moranville M. P., Rogers K. C., Trujillo T. C., Key articles of dietary interventions that influence cardiovascular mortality. Pharmacotherapy 2012 32 4 e54 e87 10.1002/j.1875-9114.2011.01087.x 2-s2.0-84864081044
5. Finegold J. A., Asaria P., Francis D. P., Mortality from ischaemic heart disease by country, region, and age: statistics from World Health Organisation and United Nations. International Journal of Cardiology 2012 168 934 945 10.1016/j.ijcard.2012.10.046 2-s2.0-84870227293
6. Lim S. S., Vos T., Flaxman A. D., A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet 2010 380 9859 2224 2260 10.1016/S0140-6736(12)61766-8
7. von Känel R., Mills P. J., Mausbach B. T., Dimsdale J. E., Patterson T. L., Ziegler M. G., Ancoli-Israel S., Allison M., Chattillion E. A., Grant I., Effect of Alzheimer caregiving on circulating levels of C-reactive protein and other biomarkers relevant to cardiovascular disease risk: a longitudinal study. Gerontology 2012 58 4 354 365 10.1159/000334219 2-s2.0-84863329164
8. Jensen M. K., Bartz T. M., Mukamal K. J., Djoussé L., Kizer J. R., Tracy R. P., Zieman S. J., Rimm E. B., Siscovick D. S., Shlipak M., Ix J. H., Fetuin-A, type 2 diabetes, and risk of cardiovascular disease in older adults: the cardiovascular health study. Diabetes Care 2013 36 5 1222 1228 10.2337/dc12-1591 2-s2.0-84876802636
9. Maréchal C., Schlieper G., Nguyen P., Krüger T., Coche E., Robert A., Floege J., Goffin E., Jadoul M., Devuyst O., Serum fetuin-A levels are associated with vascular calcifications and predict cardiovascular events in renal transplant recipients. Clinical Journal of the American Society of Nephrology 2011 6 5 974 985 10.2215/CJN.06150710 2-s2.0-79957821770
10. Zhao Z.-W., Lin C.-G., Wu L.-Z., Luo Y.-K., Fan L., Dong X.-F., Zheng H., Serum fetuin-A levels are associated with the presence and severity of coronary artery disease in patients with type 2 diabetes. Biomarkers 2013 18 2 160 164 10.3109/1354750X.2012.762806 2-s2.0-84873904158
11. Nangami G. N., Watson K., Parker-Johnson K., Okereke K. O., Sakwe A., Thompson P., Frimpong N., Ochieng J., Fetuin-A (α 2HS-glycoprotein) is a serum chemo-attractant that also promotes invasion of tumor cells through Matrigel. Biochemical and Biophysical Research Communications 2013 438 4 660 665 10.1016/j.bbrc.2013.07.125 2-s2.0-84883309176
12. Li W., Zhu S., Li J., Huang Y., Zhou R., Fan X., Yang H., Gong X., Eissa N. T., Jahnen-Dechent W., Wang P., Tracey K. J., Sama A. E., Wang H., A hepatic protein, fetuin-A, occupies a protective role in lethal systemic inflammation. PLoS ONE 2011 6 2 e16945 10.1371/journal.pone.0016945 2-s2.0-79951559422
13. Mori K., Emoto M., Inaba M., Fetuin-A and the cardiovascular system. Advances in Clinical Chemistry 2012 56 175 195 10.1016/B978-0-12-394317-0.00010-8 2-s2.0-84855302030
14. Jung C.-H., Kim B.-Y., Kim C.-H., Kang S.-K., Jung S.-H., Mok J.-O., Associations of serum fetuin-A levels with insulin resistance and vascular complications in patients with type 2 diabetes. Diabetes and Vascular Disease Research 2013 10 5 459 467 10.1177/1479164113490766 2-s2.0-84882368793
15. Fisher E., Stefan N., Saar K., Drogan D., Schulze M. B., Fritsche A., Joost H.-G., Haadiering H.-U., Hubner N., Boeing H., Weikert C., Association of AHSG gene polymorphisms with fetuin-A plasma levels and cardiovascular diseases in the EPIC-potsdam study. Circulation: Cardiovascular Genetics 2009 2 6 607 613 10.1161/CIRCGENETICS.109.870410 2-s2.0-77449147603
16. Lorant D. P., Grujicic M., Hoebaus C., Brix J.-M., Hoellerl F., Schernthaner G., Koppensteiner R., Schernthaner G.-H., Fetuin-A levels are increased in patients with type 2 diabetes and peripheral arterial disease. Diabetes Care 2011 34 1 156 161 10.2337/dc10-0788 2-s2.0-79951698612
17. Song A., Xu M., Bi Y., Xu Y., Huang Y., Li M., Wang T., Wu Y., Liu Y., Li X., Chen Y., Wang W., Ning G., Serum fetuin-A associates with type 2 diabetes and insulin resistance in Chinese adults. PLoS ONE 2011 6 4 e19228 10.1371/journal.pone.0019228 2-s2.0-79955700874
18. Lim P., Moutereau S., Simon T., Gallet R., Probst V., Ferrieres J., Gueret P., Danchin N., Usefulness of Fetuin-A and C-reactive protein concentrations for prediction of outcome in acute coronary syndromes (from the French Registry of Acute ST-elevation non-ST-elevation myocardial infarction [FAST-MI]). The American Journal of Cardiology 2013 111 1 31 37 10.1016/j.amjcard.2012.08.042 2-s2.0-84871014076
19. Basar N., Sen N., Kanat S., Ozlu M. F., Ozcan F., Cay S., Erden G., Cagli K. E., Yildirimkaya M., Maden O., Covic A., Kanbay M., Lower fetuin-A predicts angiographic impaired reperfusion and mortality in ST-elevation myocardial infarction. Journal of Investigative Medicine 2011 59 5 816 822 10.231/JIM.0b013e318214b578 2-s2.0-84856476447
20. Kadoglou N. P., Kottas G., Lampropoulos S., Vitta I., Liapis C. D., Serum levels of fetuin-A, osteoprotegerin and osteopontin in patients with coronary artery disease: effects of statin (HMGCoA-reductase inhibitor) therapy. Clinical Drug Investigation 2014 34 165 171 10.1007/s40261-013-0157-y
21. Ballestri S., Meschiari E., Baldelli E., Musumeci F. E., Romagnoli D., Trenti T., Zennaro R. G., Lonardo A., Loria P., Relationship of serum fetuin-A levels with coronary atherosclerotic burden and NAFLD in patients undergoing elective coronary angiography. Metabolic Syndrome and Related Disorders 2013 11 4 289 295 10.1089/met.2012.0149 2-s2.0-84880448050
22. Lim P., Collet J.-P., Moutereau S., Guigui N., Mitchell-Heggs L., Loric S., Bernard M., Benhamed S., Montalescot G., Randé J.-L. D., Guéret P., Fetuin-A is an independent predictor of death after ST-elevation myocardial infarction. Clinical Chemistry 2007 53 10 1835 1840 10.1373/clinchem.2006.084947 2-s2.0-34848903919
23. Voros K., Prohaszka Z., Kaszas E., Serum ghrelin level and TNF-alpha/ghrelin ratio in patients with previous myocardial infarction. Archives of Medical Research 2012 43 548 554 10.1016/j.arcmed.2012.09.002
24. Afsar C. U., Uzun H., Yurdakul S., Muderrisoglu C., Ergüney M., Demir B., Aslan A., Aral H., Ozyazgan S., Association of serum fetuin-A levels with heart valve calcication and other biomarkers of inflammation among persons with acute coronary syndrome. Clinical & Investigative Medicine 2012 35 4 E206 E215 2-s2.0-84867391800
25. Bilgir O., Kebapcilar L., Bilgir F., Bozkaya G., Yildiz Y., Pinar P., Tastan A., Decreased serum fetuin-A levels are associated with coronary artery diseases. Internal Medicine 2010 49 13 1281 1285 10.2169/internalmedicine.49.3223 2-s2.0-77954462641
26. Weikert C., Stefan N., Schulze M. B., Pischon T., Berger K., Joost H.-G., Häring H.-U., Boeing H., Fritsche A., Plasma fetuin-A levels and the risk of myocardial infarction and ischemic stroke. Circulation 2008 118 24 2555 2562 10.1161/CIRCULATIONAHA.108.814418 2-s2.0-58149393662
27. Mathews S. T., Deutsch D. D., Iyer G., Hora N., Pati B., Marsh J., Grunberger G., Plasma α 2-HS glycoprotein concentrations in patients with acute myocardial infarction quantified by a modified ELISA. Clinica Chimica Acta 2002 319 1 27 34 10.1016/S0009-8981(02)00013-X 2-s2.0-0037035390
28. Stang A., Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. European Journal of Epidemiology 2010 25 9 603 605 10.1007/s10654-010-9491-z 2-s2.0-77957661914
29. Jackson D., White I. R., Riley R. D., Quantifying the impact of between-study heterogeneity in multivariate meta-analyses. Statistics in Medicine 2012 31 29 3805 3820 10.1002/sim.5453 MR3041775 2-s2.0-84870066370
30. Peters J. L., Sutton A. J., Jones D. R., Abrams K. R., Rushton L., Comparison of two methods to detect publication bias in meta-analysis. Journal of the American Medical Association 2006 295 6 676 680 10.1001/jama.295.6.676 2-s2.0-32144440794
31. Zintzaras E., Ioannidis J. P. A., HEGESMA: genome search meta-analysis and heterogeneity testing. Bioinformatics 2005 21 18 3672 3673 10.1093/bioinformatics/bti536 2-s2.0-24644511654
32. Nordestgaard B. G., Zacho J., Lipids, atherosclerosis and CVD risk: is CRP an innocent bystander? Nutrition, Metabolism and Cardiovascular Diseases 2009 19 8 521 524 10.1016/j.numecd.2009.07.005 2-s2.0-69349104588
33. Singh M., Sharma P. K., Garg V. K., Mondal S. C., Singh A. K., Kumar N., Role of fetuin-A in atherosclerosis associated with diabetic patients. Journal of Pharmacy and Pharmacology 2012 64 12 1703 1706 10.1111/j.2042-7158.2012.01561.x 2-s2.0-84869091319
34. Mori K., Ikari Y., Jono S., Emoto M., Shioi A., Koyama H., Shoji T., Ishimura E., Inaba M., Hara K., Nishizawa Y., Fetuin-A is associated with calcified coronary artery disease. Coronary Artery Disease 2010 21 5 281 285 10.1097/MCA.0b013e32832fe5d5 2-s2.0-77954661099
35. Kanbay M., Nicoleta M., Selcoki Y., Ikizek M., Aydin M., Eryonucu B., Duranay M., Akcay A., Armutcu F., Covic A., Fibroblast growth factor 23 and fetuin A are independent predictors for the coronary artery disease extent in mild chronic kidney disease. Clinical Journal of the American Society of Nephrology 2010 5 10 1780 1786 10.2215/CJN.02560310
36. Vörös K., Prohászka Z., Kaszás E., Serum ghrelin level and TNF- α /ghrelin ratio in patients with previous myocardial infarction. Archives of Medical Research 2012 43 548 554